Hongxi X. Chen

No.28 Dianxin Nan Street
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Thymectomy promotes maintained complete stable remission in myasthenia gravis.

Thymectomy promotes maintained complete stable remission in myasthenia gravis.

Journal: Journal of neuroimmunology

Published: May 19, 2026

Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort Study.

Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort Study.

Journal: Neurology and therapy

Published: March 13, 2026

Predictors of exacerbation in myasthenia gravis after minimal symptom expression: a bicenter cohort study.

Predictors of exacerbation in myasthenia gravis after minimal symptom expression: a bicenter cohort study.

Journal: Frontiers in immunology

Published: January 12, 2026

Disrupted and reorganized connectivity of brain networks in multiple sclerosis: a systematic review and meta-analysis of resting-state functional MRI.

Disrupted and reorganized connectivity of brain networks in multiple sclerosis: a systematic review and meta-analysis of resting-state functional MRI.

Journal: Journal of neurology

Published: November 25, 2025

Dysbiosis of intestinal microbiota in patients with neuromyelitis optica spectrum disorders.

Dysbiosis of intestinal microbiota in patients with neuromyelitis optica spectrum disorders.

Journal: Frontiers in immunology

Published: November 16, 2025

Immune dysfunction contributes to comorbid depression in patients with multiple sclerosis.

Immune dysfunction contributes to comorbid depression in patients with multiple sclerosis.

Journal: Journal of affective disorders

Published: September 08, 2025

Glymphatic dysfunction in neuromyelitis optica spectrum disorder.

Glymphatic dysfunction in neuromyelitis optica spectrum disorder.

Journal: Frontiers in immunology

Published: September 04, 2025

Severe attacks and worse prognosis in patients with late-onset neuromyelitis optica spectrum disorder highlight the need for early highly effective treatment.

Severe attacks and worse prognosis in patients with late-onset neuromyelitis optica spectrum disorder highlight the need for early highly effective treatment.

Journal: Journal of neurology

Published: August 22, 2025

Association of Demographic, Clinical, and Environmental Factors With Disease Severity in Adult Myasthenia Gravis: A Multicenter Cross-Sectional Study.

Association of Demographic, Clinical, and Environmental Factors With Disease Severity in Adult Myasthenia Gravis: A Multicenter Cross-Sectional Study.

Journal: CNS neuroscience & therapeutics

Published: July 25, 2025

Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort study.

Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort study.

Journal: Clinical immunology (Orlando, Fla.)

Published: July 05, 2025

Panaxatriol saponins exert anti-renal fibrosis by suppressing TNF-α mediated inflammation and TGF-β1/Smad3 signaling pathway.

Panaxatriol saponins exert anti-renal fibrosis by suppressing TNF-α mediated inflammation and TGF-β1/Smad3 signaling pathway.

Journal: Renal failure

Published: June 19, 2025

Role of biomarker SOCS1 in peritoneal dialysis-associated peritoneal fibrosis and immune infiltration based on machine learning screening.

Role of biomarker SOCS1 in peritoneal dialysis-associated peritoneal fibrosis and immune infiltration based on machine learning screening.

Journal: Frontiers in pharmacology

Published: June 14, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026